Second Relapse of Pediatric Patients with Acute Myeloid Leukemia: A Report on Current Treatment Strategies and Outcome of the AML-BFM Study Group
Successful management of relapse is critical to improve outcomes of children with acute myeloid leukemia (AML). We evaluated response, survival and prognostic factors after a second relapse of AML. Among 1222 pediatric patients of the population-based AML-Berlin–Frankfurt–Munster (BFM) study group (...
Main Authors: | Mareike Rasche, Emma Steidel, Martin Zimmermann, Jean-Pierre Bourquin, Heidrun Boztug, Iveta Janotova, E. Anders Kolb, Thomas Lehrnbecher, Nils von Neuhoff, Naghmeh Niktoreh, Nora Mühlegger, Lucie Sramkova, Jan Stary, Christiane Walter, Ursula Creutzig, Michael Dworzak, Dirk Reinhardt |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/4/789 |
Similar Items
-
Survival Following Relapse in Children with Acute Myeloid Leukemia: A Report from AML-BFM and COG
by: Mareike Rasche, et al.
Published: (2021-05-01) -
TREATMENT OF LOW-BLAST COUNT AML USING HYPOMETHYLATING AGENTS
by: Eleonora De Bellis, et al.
Published: (2017-07-01) -
A child AML-M1 with CD79a, CD56, and CD5 coexpressions and misdiagnosed as biphenotypic acute leukemia
by: Ayşen Türedi Yıldırım, et al.
Published: (2015-03-01) -
Redirecting the Immune Microenvironment in Acute Myeloid Leukemia
by: Stephanie Sendker, et al.
Published: (2021-03-01) -
Acute Promyelocytic Leukemia (APL) Relapsing into AML-M2 with Normal Cytogenetics. A report.
by: Ranjit Kumar Sahoo, et al.
Published: (2014-08-01)